Over the last 18 months, the pendulum has swung back to aggressive FDA enforcement of current good manufacturing practices (cGMPs) for medical devices, Mark Brown, a partner with King & Spalding, said last week at the FDAnews Fourth Annual Medical Device Quality Congress.
